Back to Search
Start Over
Poster: ALL-132: Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): PhALLCON Study.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS209-S209, 1p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 21
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 152098630
- Full Text :
- https://doi.org/10.1016/S2152-2650(21)01309-4